Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Coverage, FDA Review Process Overlap Studied By HHS Secretary Panel

This article was originally published in The Gray Sheet

Executive Summary

The HHS Secretary's Advisory Committee on Regulatory Reform will consider proposals to coordinate CMS' coverage analysis process with FDA's evaluation of new technologies to prevent duplicative requirements

You may also be interested in...



Unique Missions Of FDA, CMS Underscored In Presentations To HHS Panel

Ongoing attempts to coordinate FDA and CMS reviews will preserve approval, coverage, coding and payment as distinct processes, agency representatives concurred at the HHS Secretary's Advisory Committee on Regulatory Reform regional hearing June 10

Feigal, Tunis To Present At HHS Reg Reform Panel On FDA/CMS Partnerships

Collaborative opportunities between FDA and the Centers for Medicare & Medicare Services for approving new technologies will be explored during the upcoming 1HHS Advisory Committee on Regulatory Reform's public hearing in Minneapolis

Feigal, Tunis To Present At HHS Reg Reform Panel On FDA/CMS Partnerships

Collaborative opportunities between FDA and the Centers for Medicare & Medicare Services for approving new technologies will be explored during the upcoming 1HHS Advisory Committee on Regulatory Reform's public hearing in Minneapolis

Related Content

Latest News
See All
UsernamePublicRestriction

Register

MT015932

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel